Nephrolithiasis
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Tonic - clonic seizures
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Global developmental delay
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
hearing impairment
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Adrenal hyperplasia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Decreased circulating renin level
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Pulmonary arterial hypertension
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Idiopathic pulmonary arterial hypertension
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
AV Block Second Degree by ECG Finding
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Central visual impairment
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Abnormal circulating renin
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
EMG: impaired neuromuscular transmission
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Focal myoclonic seizures
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Cortical visual impairment
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Diabetes Mellitus, Non-Insulin-Dependent
|
0.030 |
Biomarker
|
disease |
BEFREE |
The determination of the structures of the human CACNL1A2 and CACNLB3 genes should facilitate study of the role of these genes in the development of NIDDM and also other genetic diseases such as long QT syndrome.
|
7557998 |
1995 |
Long QT Syndrome
|
0.010 |
Biomarker
|
disease |
BEFREE |
The determination of the structures of the human CACNL1A2 and CACNLB3 genes should facilitate study of the role of these genes in the development of NIDDM and also other genetic diseases such as long QT syndrome.
|
7557998 |
1995 |
Hyperglycemia
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Studies of animal models with chronic hyperglycemia and starvation have indicated that the reduced CACN4 mRNA levels in pancreatic islets are associated with impaired insulin responses to stimuli in both hyperglycemic and fasting states.
|
8529524 |
1995 |
insulinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Molecular cloning of a novel alpha 1 subunit (beta-cell/neuroendocrine type, CACN4) of VDCCs from pancreatic islets and insulinoma have made it possible to study the electrophysiological and pharmacogical properties, regulation, and genetics of the VDCCs expressed in beta-cells.
|
8529524 |
1995 |
Movement Disorders
|
0.100 |
GeneticVariation
|
group |
CLINVAR |
Congenital deafness and sinoatrial node dysfunction in mice lacking class D L-type Ca2+ channels.
|
10929716 |
2000 |
Memory Disorders
|
0.200 |
Biomarker
|
disease |
RGD |
Age-related working memory impairment is correlated with increases in the L-type calcium channel protein alpha1D (Cav1.3) in area CA1 of the hippocampus and both are ameliorated by chronic nimodipine treatment.
|
12591156 |
2003 |
Movement Disorders
|
0.100 |
GeneticVariation
|
group |
CLINVAR |
Functional role of L-type Cav1.3 Ca2+ channels in cardiac pacemaker activity.
|
12700358 |
2003 |
SINOATRIAL NODE DYSFUNCTION AND DEAFNESS
|
0.720 |
Biomarker
|
disease |
CLINGEN |
Null mutation of alpha1D Ca2+ channel gene results in deafness but no vestibular defect in mice.
|
15357422 |
2004 |
Prelingual Deafness
|
0.300 |
Biomarker
|
disease |
CTD_human |
Null mutation of alpha1D Ca2+ channel gene results in deafness but no vestibular defect in mice.
|
15357422 |
2004 |
Deafness
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Null mutation of alpha1D Ca2+ channel gene results in deafness but no vestibular defect in mice.
|
15357422 |
2004 |
Hearing Loss, Extreme
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Null mutation of alpha1D Ca2+ channel gene results in deafness but no vestibular defect in mice.
|
15357422 |
2004 |